• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

走在生物医学的前沿?抗衰老医学的奇特而矛盾案例。

In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine.

机构信息

Department of Social Studies of Medicine, McGill University, Montreal, Canada.

出版信息

Sociol Health Illn. 2010 Feb 1;32(2):197-210. doi: 10.1111/j.1467-9566.2009.01212.x. Epub 2009 Dec 9.

DOI:10.1111/j.1467-9566.2009.01212.x
PMID:20003037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3414193/
Abstract

The rise of anti-ageing medicine is emblematic of the current conditions of American biomedicine. Through in-depth interviews with 31 anti-ageing practitioners, we examine how practitioners strive for-and justify-a model of care that runs counter to what they see as the 'assembly line' insurance-managed industry of healthcare. Their motivation, however, is not merely a reaction to conventional medicine. It is derived from what they see as a set of core beliefs about the role of the physician, the nature of the physician-patient relationship, and the function of biomedicine. We analyse this ideology to underscore how anti-ageing medicine is built on a 'technology of the self', a self in need of constant surveillance, intervention, and maintenance. The ultimate goal is to create an optimal self, not just a self free of illness. A fundamental irony is that, despite their self-presentation and the perception of the public, anti-ageing providers do not use practices that are especially 'high-tech' or unconventional. Instead, the management of ageing bodies rests on providers' perceived knowledge of their patients, tailored treatments, and a collaborative pact between the provider and patient.

摘要

抗衰医学的兴起是美国生物医学现状的一个象征。通过对 31 名抗衰从业者的深入访谈,我们研究了从业者如何努力争取并证明一种与他们认为的“流水线”保险管理型医疗保健行业背道而驰的护理模式是合理的。然而,他们的动机不仅仅是对传统医学的反应。它源自于他们认为的关于医生角色、医患关系性质和生物医学功能的一系列核心信念。我们分析这种意识形态,以强调抗衰医学是建立在“自我技术”之上的,这种自我需要不断的监控、干预和维护。最终目标是创造一个最佳的自我,而不仅仅是一个没有疾病的自我。一个根本的讽刺是,尽管他们自我表现和公众的看法,抗衰提供者并不使用特别“高科技”或非常规的做法。相反,衰老身体的管理依赖于提供者对患者的感知知识、量身定制的治疗方法以及提供者和患者之间的合作协议。

相似文献

1
In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine.走在生物医学的前沿?抗衰老医学的奇特而矛盾案例。
Sociol Health Illn. 2010 Feb 1;32(2):197-210. doi: 10.1111/j.1467-9566.2009.01212.x. Epub 2009 Dec 9.
2
A sociological approach to ageing, technology and health.社会学视角下的老龄化、技术与健康。
Sociol Health Illn. 2010 Feb 1;32(2):171-80. doi: 10.1111/j.1467-9566.2009.01219.x.
3
Ageing: Research needs social science.老龄化:研究需要社会科学。
Nature. 2014 Aug 21;512(7514):253. doi: 10.1038/512253e.
4
Ageing: Develop models of frailty.衰老:建立衰弱模型。
Nature. 2014 Aug 21;512(7514):253. doi: 10.1038/512253d.
5
Psychosocial models: Focus on positive features of ageing.社会心理模型:关注衰老的积极特征。
Nature. 2014 Oct 2;514(7520):35. doi: 10.1038/514035e.
6
A history of the future: the emergence of contemporary anti-ageing medicine.未来的历史:当代抗衰老医学的出现。
Sociol Health Illn. 2010 Feb 1;32(2):181-96. doi: 10.1111/j.1467-9566.2009.01217.x. Epub 2010 Feb 8.
7
[Preventive geriatrics vs anti-aging medicine].[预防性老年医学与抗衰老医学]
Adv Gerontol. 2015;28(3):589-593.
8
Medical research: treat ageing.医学研究:对抗衰老。
Nature. 2014 Jul 24;511(7510):405-7. doi: 10.1038/511405a.
9
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
10
The need to act a little more 'scientific': biomedical researchers investigating complementary and alternative medicine.需要更加“科学”地行动:研究补充和替代医学的生物医学研究人员。
Sociol Health Illn. 2010 Jan;32(1):106-22. doi: 10.1111/j.1467-9566.2009.01185.x. Epub 2009 Nov 4.

引用本文的文献

1
Differences and Disparities in Ageism Affecting Older US Adults: A Review.影响美国老年人的年龄歧视差异与不平等:一项综述
Curr Epidemiol Rep. 2023 Mar;10(1):17-32. doi: 10.1007/s40471-022-00316-6. Epub 2022 Dec 29.
2
Illegitimate bodies? Turner syndrome and the silent interplay of age, gender, and generational positions.非正统的身体?特纳综合征与年龄、性别和代际地位的无声互动
Front Sociol. 2023 Mar 8;8:1084707. doi: 10.3389/fsoc.2023.1084707. eCollection 2023.
3
Anti-aging technoscience & the biologization of cumulative inequality: Affinities in the biopolitics of successful aging.抗衰老技术科学与累积不平等的生物化:成功老龄化的生命政治亲和性。
J Aging Stud. 2020 Dec;55:100899. doi: 10.1016/j.jaging.2020.100899. Epub 2020 Oct 21.
4
Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.生物同源激素、更年期女性与美国抗衰老医学中“天然”的诱惑。
Soc Sci Med. 2015 May;132:79-87. doi: 10.1016/j.socscimed.2015.02.027. Epub 2015 Feb 19.
5
Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.深入探究制药“流水线”:研究性药物、临床试验及行业优先事项。
Soc Sci Med. 2015 Apr;131:322-30. doi: 10.1016/j.socscimed.2014.08.023. Epub 2014 Aug 19.
6
The salience of language in probing public attitudes about life extension.语言在探究公众对延长寿命态度方面的显著作用。
Am J Bioeth. 2009 Dec;9(12):81-2. doi: 10.1080/15265160903320521.

本文引用的文献

1
Anti-aging science: The emergence, maintenance, and enhancement of a discipline.抗衰老科学:一门学科的兴起、维持与发展
J Aging Stud. 2008 Dec 1;22(4):295-303. doi: 10.1016/j.jaging.2008.05.010.
2
From the Lab to the Front Line: How Individual Biogerontologists Navigate their Contested Field.从实验室到前线:个体生物老年学家如何在其充满争议的领域中前行。
J Aging Stud. 2008 Dec 1;22(4):304-312. doi: 10.1016/j.jaging.2008.05.002.
3
Anti-aging medicine: a patient/practitioner movement to redefine aging.抗衰老医学:一场重新定义衰老的患者/从业者运动。
Soc Sci Med. 2006 Feb;62(3):643-53. doi: 10.1016/j.socscimed.2005.06.021. Epub 2005 Jul 22.
4
The war on "anti-aging medicine".针对“抗衰老医学”的斗争。
Gerontologist. 2003 Feb;43(1):4-14. doi: 10.1093/geront/43.1.4.
5
The biomedicalization of aging: dangers and dilemmas.衰老的生物医学化:风险与困境
Gerontologist. 1989 Oct;29(5):587-96. doi: 10.1093/geront/29.5.587.